CA2995970A1 - Systeme de composition d'agent de melange destine aux cigarettes electroniques - Google Patents

Systeme de composition d'agent de melange destine aux cigarettes electroniques Download PDF

Info

Publication number
CA2995970A1
CA2995970A1 CA2995970A CA2995970A CA2995970A1 CA 2995970 A1 CA2995970 A1 CA 2995970A1 CA 2995970 A CA2995970 A CA 2995970A CA 2995970 A CA2995970 A CA 2995970A CA 2995970 A1 CA2995970 A1 CA 2995970A1
Authority
CA
Canada
Prior art keywords
cannabinoid
distillate
terpene
propenediol
electronic cigarette
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2995970A
Other languages
English (en)
Inventor
Gene Bernaudo
Santino Bernaudo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2995970A1 publication Critical patent/CA2995970A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10Chemical features of tobacco products or tobacco substitutes
    • A24B15/16Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A24B15/167Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24FSMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F47/00Smokers' requisites not otherwise provided for
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pyrane Compounds (AREA)
CA2995970A 2017-02-22 2018-02-22 Systeme de composition d'agent de melange destine aux cigarettes electroniques Abandoned CA2995970A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762462255P 2017-02-22 2017-02-22
US62/462,255 2017-02-22

Publications (1)

Publication Number Publication Date
CA2995970A1 true CA2995970A1 (fr) 2018-08-22

Family

ID=63245253

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2995970A Abandoned CA2995970A1 (fr) 2017-02-22 2018-02-22 Systeme de composition d'agent de melange destine aux cigarettes electroniques

Country Status (2)

Country Link
CA (1) CA2995970A1 (fr)
WO (1) WO2018152637A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020093170A1 (fr) * 2018-11-09 2020-05-14 Cronos Group Inc. Composition liquide pour un dispositif à vapeur électronique
WO2022232574A1 (fr) * 2021-04-29 2022-11-03 Tilray, Inc. Formulations dans lesquelles le cannabidiol est le constituant dominant, leurs procédés de fabrication et leurs utilisations

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
WO2019152736A1 (fr) 2018-01-31 2019-08-08 Canopy Holdings, LLC Poudre de chanvre
WO2020077153A1 (fr) 2018-10-10 2020-04-16 Canopy Holdings, LLC Synthèse du cannabigérol
EP3880184A4 (fr) * 2018-11-13 2022-09-28 Hexo Operations Inc. Procédé de fabrication d'huile de vapotage comprenant un cannabinoïde destiné à être utilisé dans un dispositif de vapotage
US11517044B2 (en) * 2019-08-23 2022-12-06 Mabee Engineered Solutions Inc. Vaporizer apparatus
US11606980B2 (en) * 2019-08-23 2023-03-21 Mabee Engineered Solutions, Inc. Vaporizer apparatus having both a vacuum pump and a heating element, and method of using same
FR3119517B1 (fr) * 2021-02-08 2024-04-12 Sebastien Ombe Composition vaporisable de liquide pour cigarette électronique renfermant au moins un diol, ainsi que de la nicotine et au moins un composé cannabinoïde exempt de delta-9-tétrahydrocannabinol.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9326967B2 (en) * 2013-08-22 2016-05-03 Stephen C. Perry Vaporizable cannabinoid compositions
WO2015117243A1 (fr) * 2014-02-07 2015-08-13 Bellerose Samuel Composition liquide pour e-cigarettes
GB2524469A (en) * 2014-02-14 2015-09-30 Kind Consumer Ltd A cannabinoid inhaler and composition therefor
FR3015186A1 (fr) * 2014-03-11 2015-06-26 Antoine Piccirilli Utilisation d'une composition renfermant du 1,3-propanediol comme e-liquide
WO2016019353A1 (fr) * 2014-07-31 2016-02-04 MJAR Holdings, LLC Cigarettes électroniques, cartouches et préparations inhalables à base de composés de cannabis à usage thérapeutique et appareils et procédés permettant de les fabriquer et de les utiliser
CA3186297A1 (fr) * 2016-09-15 2018-03-15 Markham Biotech Inc. Formulations de cannabinoide destinees a des dispositifs aerosols et methodes associees
US11660403B2 (en) * 2016-09-22 2023-05-30 Juul Labs, Inc. Leak-resistant vaporizer device

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020093170A1 (fr) * 2018-11-09 2020-05-14 Cronos Group Inc. Composition liquide pour un dispositif à vapeur électronique
WO2022232574A1 (fr) * 2021-04-29 2022-11-03 Tilray, Inc. Formulations dans lesquelles le cannabidiol est le constituant dominant, leurs procédés de fabrication et leurs utilisations
US12029720B2 (en) 2021-04-29 2024-07-09 Tilray Brands, Inc. Cannabidiol-dominant formulations, methods of manufacturing, and uses thereof

Also Published As

Publication number Publication date
WO2018152637A1 (fr) 2018-08-30

Similar Documents

Publication Publication Date Title
CA2995970A1 (fr) Systeme de composition d'agent de melange destine aux cigarettes electroniques
US9333229B2 (en) Winterized crude cannabis extracts and methods of preparation and use
US11040295B2 (en) Method and apparatus for extracting plant oils using ethanol water
Giroud et al. E-cigarettes: a review of new trends in cannabis use
WO2015042589A1 (fr) Liquide de vaporisateur personnel pour émulsifier des composés ou des résines solubles dans l'huile
US20210267935A1 (en) Cannabis product
TW201138920A (en) Methods for extracting and isolating constituents of cellulosic material
US20210392943A1 (en) Liquid composition for an electronic vapor device
WO2019131579A1 (fr) Extrait de tabac, procédé d'obtention d'extrait de tabac et inhalateur d'arôme sans combustion comprenant un extrait de tabac
FR3062303A1 (fr) Formulation liquide vaporisable comprenant au moins un diol et au moins un compose cannabinoide
JP2022506064A (ja) エアロゾル化された配合物
KR101623426B1 (ko) 무화기용 액상 조성물 및 그의 제조방법
RU2745353C1 (ru) Ароматизированная испаряемая композиция
Rao et al. Extraction of essential oil and its applications
WO2019011664A1 (fr) Composition comprenant un parfum destinée à être utilisée en tant que composition de réadaptation pour toxicomanes
KR20030040514A (ko) 점안제
US20230083927A1 (en) Electronic vapor liquid composition and method of use
WO2021080535A2 (fr) Mélange d'huiles essentielles renforçant la mémoire
RU2093171C1 (ru) Лекарственное средство
Sambiagio et al. Toxicological assessment of aerosols emitted by cannabis inhalation methods: Does cannabis vaping using Electronic Non-Nicotine Delivery Systems (ENNDS) and vaporizers reduce exposure to toxicants compared to cannabis smoking?
JP7334104B2 (ja) 認知症改善および/または予防剤
US20230248051A1 (en) Flavoring solution
EP3918927A1 (fr) E-liquide pour la vapotage comprenant un agent formant un aérosol et son procédé de production
Li Aerosolization and Thermal Degradation Chemistry of Electronic Cigarettes
Wigglesworth Vaping Synthetic Cannabinoids: Degradation Study and Putative Production of Toxic Compounds

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20210831

FZDE Discontinued

Effective date: 20210831